Your browser doesn't support javascript.
["Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism].
Chazova, I E; Martynyuk, T V; Gorbachevskii, S V; Gramovich, V V; Danilov, N M; Panchenko, E P; Chernyavskiy, A M; Shmalts, A A; Yavelov, I S.
  • Chazova IE; Chazov National Medical Research Center of Cardiology.
  • Martynyuk TV; Chazov National Medical Research Center of Cardiology.
  • Gorbachevskii SV; The Russian National Research Medical University named after N.I. Pirogov.
  • Gramovich VV; Bakoulev Scientific Center for Cardiovascular Surgery.
  • Danilov NM; Russian Medical Academy of Continuous Professional Education.
  • Panchenko EP; Chazov National Medical Research Center of Cardiology.
  • Chernyavskiy AM; Chazov National Medical Research Center of Cardiology.
  • Shmalts AA; Chazov National Medical Research Center of Cardiology.
  • Yavelov IS; E. Meshalkin National Medical Research Center.
Ter Arkh ; 94(9): 1052-1056, 2022 Oct 24.
Article in Russian | MEDLINE | ID: covidwho-2228758
ABSTRACT
On December 13, 2021, an expert council was held to determine the position of experts of different specialties regarding the reasons for the low level of diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) in real clinical practice in a pandemic of a new coronavirus infection and possible ways to improve detection in patients with pulmonary embolism (PE) ) in history. The reasons for the low level of diagnosis of CTEPH are the insufficient level of knowledge of specialists, especially primary care physicians; lack of clear regulatory documents and expert centers for the management of this category of patients. Primary diagnosis of CTEPH in a pandemic can be strengthened through the widespread use of telemedicine for consultations of primary care physicians with specialists from expert centers; to maximize the role of echocardiography and computed tomography (CT) as differential diagnostic tools for dyspnea, in particular in patients with COVID-19. To increase the detection rate of CTEPH, diagnostic vigilance is required in patients with risk factors and episodes of venous thromboembolism. To improve the screening of CTEPH, it is necessary to create an algorithm for monitoring patients who have had PE; provide educational activities, including through the media; create materials for patients with accessible information. The regulatory documents should designate the circle of responsible specialists who will be engaged in long-term monitoring of patients with PE. Educational programs are needed for primary care physicians, cardiologists, and other physicians who come into the field of view of patients with CTEPH; introduction of a program to create expert centers for monitoring and managing patients with the possibility of performing ventilation-perfusion lung scintigraphy, cardiopulmonary stress test, CT, right heart catheterization. It seems important to build cooperation with the Ministry of Health of Russia in order to create special protocols, procedures for managing patients with PE and CTEPH.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Embolism / COVID-19 / Hypertension, Pulmonary Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: Russian Journal: Ter Arkh Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Embolism / COVID-19 / Hypertension, Pulmonary Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: Russian Journal: Ter Arkh Year: 2022 Document Type: Article